Vanguard Group Inc Acadia Pharmaceuticals Inc Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Vanguard Group Inc holds 13,843,196 shares of ACAD stock, worth $238 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,843,196
Previous 13,712,131
0.96%
Holding current value
$238 Million
Previous $223 Million
4.39%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ACAD
# of Institutions
279Shares Held
156MCall Options Held
901KPut Options Held
314K-
Baker Bros. Advisors LP New York, NY42.9MShares$736 Million7.07% of portfolio
-
Rtw Investments, LP New York, NY13.7MShares$235 Million3.36% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$207 Million0.0% of portfolio
-
State Street Corp Boston, MA5.97MShares$103 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.5MShares$60.2 Million0.05% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.78B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...